[News Focus] Why Kim Jong-un spotlights mothers
Korean students outperform OECD average amid pandemic havoc: data
LG Display launches voluntary redundancy program in efficiency drive
‘Korea could go extinct without proper immigration policy’: minister
S. Korea, US, Japan to discuss regional security issues: White House
Samsung BioLogics seek to raise over W2tr via IPOBy 박한나
Published : Oct. 4, 2016 - 14:38
According to a securities registration statement of Samsung Group’s biopharmaceutical contract manufacturing arm on Oct. 4, it will seek to sell some 16.54 million shares at 113,000 won to 136,000 won.
If the company prices its IPO at the top end of its proposed range, it could raise 2.249 trillion won.
It will take investor orders on Nov. 2-3.
By Park Han-na (firstname.lastname@example.org)
Suneung without 'killer questions' still not easy, results show
SK carries out complete reshuffle of top brass
Investigators, not teachers, to handle school violence